News UK launches review of clinical trials amid worrying decline Review comes after drug industry saw a 41% decline in new trial starts between 2017 and 2021.
News Regeneron is off to CHAPLE as FDA starts pozelimab review The C5 inhibitor is vying to become the first approved drug for the ultra-rare immune disorder.
News Hemab raises $135m for rare bleeding disorder trials Cash will be used to advance drugs for Glanzmann thrombasthenia and von Willebrand disease.
News Actinium radioligand aces AML trial as filings beckon Survival doubled when Iomab-B was used as a conditioning regimen before a stem cell transplant.
News Protocol violations gut Pfizer’s Lyme disease shot study 50% of US patients in the VALOR study of VLA15 will be discontinued from the trial.
News Aera Tx launches with $193m in financing for genetic meds Aera Therapeutics announces launch with $193m financing from leading life sciences investors.
News Pharvaris plans filings for HAE drug after pivotal trial win Pharvaris has reported positive data from a phase 3 trial of its drug for preventing HAE attacks, setting up marketing applications next year.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
